<bill session="104" type="h" number="448" updated="2013-07-14T18:47:10-04:00">
  <state datetime="1995-01-09">REFERRED</state>
  <status>
    <introduced datetime="1995-01-09"/>
  </status>
  <introduced datetime="1995-01-09"/>
  <titles>
    <title as="introduced" type="short">Myelogram-Related Arachnoiditis Amendments of 1995</title>
    <title as="introduced" type="official">To amend the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act with respect to myelogram-related arachnoiditis.</title>
  </titles>
  <sponsor id="400611"/>
  <cosponsors>
    <cosponsor id="400123" joined="1996-04-23"/>
  </cosponsors>
  <actions>
    <action state="REFERRED" datetime="1995-01-09">
      <text>Referred to the House Committee on Commerce.</text>
    </action>
    <action datetime="1995-01-11">
      <text>Sponsor introductory remarks on measure.</text>
      <reference ref="CR E77"/>
    </action>
    <action datetime="1995-02-06">
      <text>Referred to the Subcommittee on Health and Environment.</text>
      <committee name="House Committee on Commerce"/>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Commerce" activity="Referral, In Committee"/>
    <committee activity="Referral" code="HSIF04" subcommittee="Health and Environment" name="House Commerce"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Medical research"/>
    <term name="Medical statistics"/>
    <term name="Medical tests"/>
    <term name="Nervous system diseases"/>
    <term name="Neurology"/>
    <term name="Pain"/>
    <term name="Science, technology, communications"/>
  </subjects>
  <amendments/>
  <summary>1/9/1995--Introduced.
Myelogram-Related Arachnoiditis Amendments of 1995 - Amends the Federal Food, Drug, and Cosmetic Act to prohibit a myelogram involving the use of Pantopaque, Amipaque, Omipacque, or Isovue. Amends the Public Health Service Act to require a study and research with respect to individuals who have undergone a myelogram and who have subsequently developed arachnoiditis.</summary>
</bill>
